2016 Innovation Grants - Prof. Helge Rasmussen
Research
New therapeutic tools
Prof. Helge Rasmussen
Grant
A novel therapeutic target in pancreatic cancer: Implications for therapy and diagnosis
Award
2016 Innovation Grant
Institution
University of Sydney
Pancreatic cancers have a very poor prognosis and the project team have discovered that a protein derivative sensitises cancer cells to currently used treatments, potentially making highly treatment-resistant pancreatic cancers responsive to chemotherapy and/or radiotherapy. The augmentation treatment effect by the derivative will be examined in human pancreatic cancers expressed in mice.
Dr Helge Rasmussen, University of Sydney